體外診斷試劑（IVD）原料市場：按產品、技術、最終用戶和地區分類

IVD Raw Materials Market, By Product, By Technology, By End-User, By Geography

出版日期: 2026年03月26日 | 出版商:

Coherent Market Insights | 英文 152 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2026年體外診斷（IVD）原物料市場規模預估為342.816億美元，預計2033年將達507.906億美元。預計2026年至2033年，該市場將以5.8%的複合年成長率成長。

分析範圍		分析詳情
基準年	2025	市場規模（2026 年）	342.816億美元
效能數據	2020-2024	預測期	2026-2033
預測期（2026-2033 年）複合年成長率	5.80%	預計金額（2033 年）	507.906億美元

體外診斷 (IVD) 檢測可以檢測疾病和病症，監測整體健康狀況，並輔助疾病的治療、管理和/或預防。 IVD 檢測用於診斷多種疾病，包括心血管疾病、癌症、糖尿病、感染疾病、腎臟疾病、自體免疫疾病和 HIV/AIDS。 IVD 檢測使用取自人體的血液或組織樣本進行。簡而言之，IVD 原料用於確定人體的健康狀況。 IVD 試劑和試劑盒的關鍵原料包括抗體、抗原和酶，這些是決定試劑和試劑盒品質和有效性的關鍵因素。

市場動態

COVID-19 疫情、慢性病的高發生率、體外診斷技術的進步、照護現場普及、老年人口的成長以及伴隨診斷的重要性日益增加，這些都是預計在預測期內推動全球 IVD 原料市場成長的關鍵因素。

2021年8月，羅氏公司獲得FDA核准，其VENTANA MMR RxDx Panel是一種用於識別符合抗PD-1免疫療法條件的dMMR固體癌患者的診斷性PCR檢測。此外，2020年5月，ERBA 食品藥物管理局 Mannheim GmbH宣布推出ErbaLisa COVID-19 ELISA試劑盒，這是一種基於免疫檢測的試劑盒，用於檢測針對SARS-CoV-2的IgG和IgM抗體。 2020年3月，雅培公司推出了RealTime SARS-CoV-2檢測，這是一種用於診斷COVID-19的PCR檢測；Biomedomics公司推出了照護現場COVID-19檢測，可在15分鐘內檢測血液中的抗體。

本報告的主要特點

本報告對全球體外診斷原料市場進行了詳細分析，包括預測期（2022-2030 年）的市場規模和複合年成長率，以 2021 年為基準年。
此外，它還確定了每個細分市場的潛在商機，並描述了該市場中一系列有吸引力的投資提案。
此外，它還提供了有關市場促進因素和限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要企業採取的競爭策略的重要見解。
本文檔根據以下參數介紹了全球體外診斷原料市場主要企業的概況：公司概況、產品系列、主要亮點、財務表現和策略。
本報告中的見解將使負責人和企業經營團隊能夠就未來的產品發布、產品線更新、市場擴張和行銷策略做出明智的決策。
《全球體外診斷原料市場》報告面向該產業的眾多相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過分析全球體外診斷原料市場中使用的各種策略矩陣來促進決策。

北美洲
美國
加拿大
歐洲
德國
英國
法國
義大利
西班牙
俄羅斯
其他歐洲國家
亞太地區
中國
印度
日本
澳洲
韓國
ASEAN
其他亞太地區
拉丁美洲
巴西
墨西哥
阿根廷
其他拉丁美洲
中東和非洲
波灣合作理事會（GCC）國家
以色列
其他中東國家
南非
中非
北非
世界其他地區

第8章競爭情勢

Aalto Bio Reagents
Fapon Biotech
Fujirebio
Merck KgaA
Hoffmann-La Roche
Thermo Fisher Scientific

第9章

分析方法
關於 Coherent Market Insights

簡介目錄

Product Code: CMI5234

IVD Raw Materials Market is estimated to be valued at USD 34,281.6 Mn in 2026 and is expected to reach USD 50,790.6 Mn by 2033, growing at a compound annual growth rate (CAGR) of 5.8% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 34,281.6 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	5.80%	2033 Value Projection:	USD 50,790.6 Mn

In vitro diagnostics can detect diseases/conditions, and can be used to monitor overall health to help cure, treat, and/or prevent diseases. In vitro diagnostics are utilized to diagnose a wide range of medical disorders, such as cardiovascular disease, cancer, diabetes, infectious disease, nephrology, autoimmune diseases, and HIV/AIDS. IVD are tests done on the blood sample or tissue sample that have been taken from the human body. In short, IVD raw materials used to determine the status of a person's health. The core raw materials of in vitro diagnostic (IVD) reagents/kits include antibodies, antigens, enzymes, etc., which are important determinants of the quality and effectiveness of the reagents/kits.

Market Dynamics

The outbreak of COVID-19, high prevalence of chronic diseases, advanced technologies in in vitro diagnostic products, rise in use of point-of-care diagnostics, rising geriatric population, and growing significance of companion diagnostics are some major factors expected to boost the growth of the global IVD raw materials market during the forecast period.

In August 2021, Roche received the U.S. Food and Drug Administration (FDA) approval for VENTANA MMR RxDx Panel to identify dMMR solid tumor patients eligible for anti-PD-1 immunotherapy. Moreover, in May 2020, ERBA Diagnostics Mannheim GmbH announced the launch of its immunoassay-based kit, ErbaLisa COVID-19 ELISA kits, for the detection of IgG and IgM antibodies to SARS-CoV-2. In March 2020, Abbott launched the RealTime SARS-CoV-2 assay, a PCR-based test, for the diagnosis of COVID-19, and BioMedomics launched a point-of-care COVID-19 test that can detect antibodies in blood within 15 minutes.

Key features of the study

This report provides in-depth analysis of the global IVD raw materials market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global IVD raw materials market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Aalto Bio Reagents, Fapon Biotech, Fujirebio, Merck KgaA, F. Hoffmann-La Roche, Thermo Fisher Scientific, among others.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global IVD raw materials market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global IVD raw materials market.

Market Segmentation

Global IVD Raw Materials Market, By Product
- Antibodies & Antigens
- Enzymes
- Proteins
- Biological Buffers
- Others
Global IVD Raw Materials Market, By Technology
- Clinical Chemistry
- Immunochemistry
- Molecular diagnostics
- Others
Global IVD Raw Materials Market, By End-User
- Pharma, Biotech & MedTech Companies
- Diagnostic Laboratories
- Others
Global IVD Raw Materials Market, By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Global IVD Raw Materials Market: Key Players
- Aalto Bio Reagents
- Fapon Biotech
- Fujirebio
- Merck KgaA
- Hoffmann-La Roche
- Thermo Fisher Scientific

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Technology
- Market Snapshot, By End User
- Market Snapshot, By Geography
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global IVD Raw Materials Market, By Product, 2026-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
Antibodies & Antigens
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
Enzymes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
Proteins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
Biological Buffers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

5. Global IVD Raw Materials Market, Technology, 2026-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
Clinical Chemistry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
Immunochemistry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
Molecular diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

6. Global IVD Raw Materials Market, By End User, 2026-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
Pharma, Biotech & MedTech Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

7. Global IVD Raw Materials Market, By Geography, 2026-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026-2033, (USD Mn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026-2033, (USD Mn)
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026-2033, (USD Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026-2033, (USD Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East and Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026-2033, (USD Mn)
GCC
Israel
Rest of Middle East
South Africa
Central Africa
North Africa
Rest of World

8. Competitive Landscape

Aalto Bio Reagents
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Fapon Biotech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Fujirebio
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck KgaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Hoffmann-La Roche
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Analyst Views